Relegare Agro Life Bio Science Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-12-2024
- Paid Up Capital ₹ 2.50 M
as on 16-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.03 Cr
as on 16-12-2024
- Revenue 38.84%
(FY 2022)
- Profit 57.88%
(FY 2022)
- Ebitda -22.53%
(FY 2022)
- Net Worth 29.85%
(FY 2022)
- Total Assets -3.25%
(FY 2022)
About Relegare Agro Life Bio Science
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹1.03 Cr.
Dhanashree Gadekar and Gorakh Gadekar serve as directors at the Company.
- CIN/LLPIN
U24231PN2016PTC165703
- Company No.
165703
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Ahmed Nagar, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Relegare Agro Life Bio Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhanashree Gadekar  | Director | 26-Jul-2016 | Current |
| Gorakh Gadekar | Director | 26-Jul-2016 | Current |
Financial Performance of Relegare Agro Life Bio Science.
Relegare Agro Life Bio Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.84% increase. The company also saw a substantial improvement in profitability, with a 57.88% increase in profit. The company's net worth Soared by an impressive increase of 29.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Relegare Agro Life Bio Science?
In 2019, Relegare Agro Life Bio Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Relegare Agrochem Industries Private LimitedActive 8 years 6 monthsGorakh Gadekar is a mutual person
Charges (Loans)
₹10.26 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2017 | Others | ₹1.03 Cr | Open |
How Many Employees Work at Relegare Agro Life Bio Science?
Unlock and access historical data on people associated with Relegare Agro Life Bio Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Relegare Agro Life Bio Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relegare Agro Life Bio Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.